<?xml version="1.0" encoding="UTF-8"?>
<p>In Croatia and India, the Leningrad-3-Zagreb (L-Zagreb) strain was developed by further passage of the Leningrad-3 mumps virus by adaptation in chick embryo fibroblast cell culture [
 <xref rid="B79-ijerph-17-01686" ref-type="bibr">79</xref>,
 <xref rid="B102-ijerph-17-01686" ref-type="bibr">102</xref>]. The L-Zagreb strain has been used to prepare mumps vaccines. Between 1976 and 1987, it was estimated that over 10 million doses of the L-Zagreb mumps vaccine were used in the former Yugoslavia and elsewhere [
 <xref rid="B102-ijerph-17-01686" ref-type="bibr">102</xref>]. A study showed that the positive rate of IgG levels four weeks after immunization rose from 12% to 92% for mumps, with a vaccine efficacy of 97%â€“100% [
 <xref rid="B103-ijerph-17-01686" ref-type="bibr">103</xref>]. Only mild side effects, including pain and swelling in 37 (4.3%) cases, mild fever in 51 (5.9%) cases, cough in 40 (4.6%) cases, and a transient rash in seven (0.8%) cases, were observed [
 <xref rid="B103-ijerph-17-01686" ref-type="bibr">103</xref>]. In Croatia, there were 90 cases of aseptic meningitis per 100,000 doses of MMR vaccine containing the L-Zagreb mumps strain between 1988 and 1992 [
 <xref rid="B104-ijerph-17-01686" ref-type="bibr">104</xref>]; this finding is similar to the finding reported by Cizman et al. (10 per 10,000) [
 <xref rid="B101-ijerph-17-01686" ref-type="bibr">101</xref>].
</p>
